Analyst Ratings for Spring Works Therapeutics (SWTX)
SWTX Rating Summary
SWTX Price Target Summary
- Highest: $136.00 (H.C. Wainwright)
- Lowest: $71.00 (Credit Suisse)
- Average: $106.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$106.00 (+24.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$106.00 (+24.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/22/2021 | Goldman Sachs » Updated 7/20/2021 |
Corinne Jenkins | New Coverage | Buy (N/A) |
123.00 (107.00) |
68.20 (85.36) |
25.16% | Details |
| 5/5/2020 | Barclays » Updated 2/26/2021 |
Peter Lawson | New Coverage | Overweight (N/A) |
105.00 (92.00) |
30.21 (85.36) |
182.56% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
